3D models
| 6 min read
NAMs are increasingly used to de-risk preclinical development decisions, yet their broader impact on toxicology will depend on whether they are required or simply encouraged by regulators.
| 6 min read
Despite growing regulatory acceptance, widespread adoption of NAMs depends on workflow integration, reproducibility, and perceived risk in industry decision-making.
| 3 min read
Tools provide standardized, population-informed proteomics data to benchmark emerging in vitro systems for safer, more predictive drug development.
| 8 min read
3D bioprinted models of the tumor microenvironment could make the preclinical research process more reliable and accelerate translation to the clinic.
| 4 min read
When a research question can’t be answered using the tools available, bioengineer Kiana Aran makes new tools. Recently, she developed a new type of brain-on-a-chip to answer questions about the blood brain barrier.
Available on Demand
LIVE October 12th, 2021 at 11:30 AM ET
Bill Thelin will discuss how intestine-on-a chip technology reliably models gastrointestinal disease and assists researchers in screening for safe, effective therapeutic candidates.
Page 1 of 1 - 6 Total Items
